PreveCeutical Medical Inc. (CSE:PREV)
Canada · Delayed Price · Currency is CAD 0.0200
+0.0050 (33.33%)
Sep 17, 2026, 9:04 AM EST
PreveCeutical Medical Market Cap
PreveCeutical Medical has a market cap or net worth of CAD 12.76 million as of September 18, 2026. Its market cap has decreased by -37.85% in one year.
Market Cap
12.76M
Enterprise Value
17.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since July 14, 2017, PreveCeutical Medical's market cap has increased from 6.06M to 12.76M, an increase of 110.53%. That is a compound annual growth rate of 8.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 12.76M | -14.65% |
| Dec 31, 2025 | 14.95M | 10.43% |
| Dec 31, 2024 | 13.54M | 1.20% |
| Dec 29, 2023 | 13.38M | - |
| Dec 30, 2022 | 13.38M | 4.61% |
| Dec 29, 2021 | 12.79M | -13.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pharmala Biotech Holdings | 27.42M |
| Devonian Health Group | 23.98M |
| Alzai Health | 23.97M |
| Lobe Sciences | 23.77M |
| Hemostemix | 14.80M |
| Rapid Dose Therapeutics | 14.33M |
| Britannia Life Sciences | 11.52M |
| Rakovina Therapeutics | 10.70M |